Q5PQS3
Gene name |
Veph1 |
Protein name |
Ventricular zone-expressed PH domain-containing protein homolog 1 |
Names |
Protein melted homolog |
Species |
Rattus norvegicus (Rat) |
KEGG Pathway |
rno:361954 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q5PQS3
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q5PQS3-F1 | Predicted | AlphaFoldDB |
3 variants for Q5PQS3
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3319573111 | 226 | A>T | No | EVA | |
| rs199206797 | 540 | P>L | No | EVA | |
| rs106553044 | 692 | E>K | No | EVA |
No associated diseases with Q5PQS3
1 regional properties for Q5PQS3
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Pleckstrin homology domain | 716 - 820 | IPR001849 |
1 GO annotations of cellular component
| Name | Definition |
|---|---|
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| phosphatidylinositol-5-phosphate binding | Binding to phosphatidylinositol-5-phosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 5' position. |
3 GO annotations of biological process
| Name | Definition |
|---|---|
| negative regulation of SMAD protein signal transduction | Any process that decreases the rate, frequency or extent of the SMAD protein signaling pathway. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways. |
| negative regulation of transforming growth factor beta receptor signaling pathway | Any process that stops, prevents, or reduces the frequency, rate or extent of any TGF-beta receptor signaling pathway. |
| regulation of signal transduction | Any process that modulates the frequency, rate or extent of signal transduction. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MHQLFRLVLG | QKDLSRAGDL | FSLDDAEIED | SLTEALEQIK | VISSSLDYQT | NNNDQAVVEI |
| 70 | 80 | 90 | 100 | 110 | 120 |
| CITRITTAIR | ETESIEKHAR | ALVGLWDSCL | EHNLRPAGKD | EDTPHAKIAS | DIMSCILQNY |
| 130 | 140 | 150 | 160 | 170 | 180 |
| NRTPVMVLAV | PIAVKFLHRG | SKELCRNMSN | YLSLAAITKA | DLLADHTEGI | VKSILQGNAM |
| 190 | 200 | 210 | 220 | 230 | 240 |
| LLRVLPAVYE | KQPQPINRHL | AELLALMSQL | EQTEQYHLLR | LLHVAAKRKD | VEVVQKCVPF |
| 250 | 260 | 270 | 280 | 290 | 300 |
| LIRNLKESTY | NDIILNILIE | IAGHEPLALN | SFLPMLKEIA | EQFPYLTGQM | ARIFGAVGHV |
| 310 | 320 | 330 | 340 | 350 | 360 |
| DEERARSCLR | YLVSQLANME | HSFHHILLLE | IKSLTDAFSS | ILGPHSRDIF | RMSNSFTNIA |
| 370 | 380 | 390 | 400 | 410 | 420 |
| KLLSRQLENS | KAESGRRRTG | TEVSFPEKFR | EPKTMEPKSE | DHEKLQVKIQ | AFEDKINAES |
| 430 | 440 | 450 | 460 | 470 | 480 |
| HTPGSVRRYS | LDHVSKEERK | NVRFSRSRSL | ALNTVLTNSV | NVEDGEIEGK | TGMHASISLS |
| 490 | 500 | 510 | 520 | 530 | 540 |
| EIDPPGHGIG | KVPFKTDTHG | SQLRNSSASH | PSIIHSEPEN | MPETFKENVQ | EEIPEAAISP |
| 550 | 560 | 570 | 580 | 590 | 600 |
| VEYQDKLYLH | LKENLSKVKA | YALEIAKKVP | IPDQCTIEDN | TRSCVAKLFF | TCSLKGHYCL |
| 610 | 620 | 630 | 640 | 650 | 660 |
| YSKSSFTLVS | QAPQPWIQIM | FLFQQSLFPE | PLSIQSGSVQ | FLKALWEKTQ | GTGTHSFEVA |
| 670 | 680 | 690 | 700 | 710 | 720 |
| MTESTFPQQK | DLDQLQLHLE | EVRFFDVFGF | SETAGAWQCF | MCNNPEKATV | INQDGQPLIE |
| 730 | 740 | 750 | 760 | 770 | 780 |
| GKLKEKQVRW | KFIKRWKTRY | FTLAGNQLLF | QKGKSDDPDD | SPIELSKVQS | VKAVAKKRRD |
| 790 | 800 | 810 | 820 | 830 | |
| RSLPRAFEIF | TDNKTYVFKA | KDEKNAEEWL | QCINVALAQA | KERESREVTT | YL |